Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust – Trademark Portfolio
Entity Type: 17
Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. The owner is based in Port Royal, PA.
RR #1, Box 839
Port Royal, PA 17082
Showing of trademarks Trademarks
Trademark Classifications
Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust have?
Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust has 1 U.S. trademark filed with the USPTO.
What trademark classes does Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust file in?
Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What is Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust's trademark registration success rate?
Cassandra Bryan, Gilda Dixon, Charles Schlenz, Trustees of Day Memorial Trust has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.